Literature DB >> 2680078

Amantadine: a new clinical profile for traumatic brain injury.

T Gualtieri1, M Chandler, T B Coons, L T Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2680078

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  10 in total

1.  Cognitive Impairment Following Traumatic Brain Injury.

Authors:  David B. Arciniegas; Kerri Held; Peter Wagner
Journal:  Curr Treat Options Neurol       Date:  2002-01       Impact factor: 3.598

2.  Amantadine treatment of a patient with anoxic brain injury.

Authors:  K Edby; J Larsson; M Eek; L von Wendt; B Ostergård
Journal:  Childs Nerv Syst       Date:  1995-10       Impact factor: 1.475

Review 3.  Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review.

Authors:  David J Gagnon; Angela M Leclerc; Richard R Riker; Caitlin S Brown; Teresa May; Kristina Nocella; Jennifer Cote; Ashley Eldridge; David B Seder
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

4.  Prescribing of potentially harmful drugs to patients admitted to hospital after head injury.

Authors:  L B Goldstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

Review 5.  Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.

Authors:  James W Bales; Amy K Wagner; Anthony E Kline; C Edward Dixon
Journal:  Neurosci Biobehav Rev       Date:  2009-04-01       Impact factor: 8.989

6.  Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.

Authors:  M I Botez; T Botez-Marquard; R Elie; O L Pedraza; K Goyette; R Lalonde
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

7.  Neuropsychiatric Aspects of Traumatic Brain Injury.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

8.  Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.

Authors:  David B Arciniegas; C Alan Anderson; Jeannie Topkoff; Thomas W McAllister
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

9.  Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury.

Authors:  Sajad Shafiee; Saeed Ehteshami; Mahmood Moosazadeh; Saeed Aghapour; Kaveh Haddadi
Journal:  Caspian J Intern Med       Date:  2022

Review 10.  Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.

Authors:  Wojciech Danysz; Andrzej Dekundy; Astrid Scheschonka; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2021-02-23       Impact factor: 3.575
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.